Colonial Trust Advisors Abbott Laboratories Transaction History

Colonial Trust Advisors

$1.19 Billion
Q2 2025

A detailed history of Colonial Trust Advisors transactions in Abbott Laboratories stock. As of the latest transaction made, Colonial Trust Advisors holds 3,840 shares of ABT stock, worth $503,116. This represents 0.04% of its overall portfolio holdings.

Number of Shares

3,840

Previous 3,867 0.7%

Holding current value

$503,116

Previous $512,000 1.95%

% of portfolio

0.04%

Previous 0.05%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 13, 2025	SELL	$123.95 - $138.08 $3,346 - $3,728	-27 Reduced 0.7%	3,840 $522,000
Q1 2025 May 13, 2025	SELL	$111.1 - $140.22 $2,333 - $2,944	-21 Reduced 0.54%	3,867 $512,000
Q4 2024 Feb 13, 2025	SELL	$111.93 - $119.39 $35,146 - $37,488	-314 Reduced 7.47%	3,888 $439,000
Q3 2024 Nov 12, 2024	SELL	$100.07 - $118.13 $5,003 - $5,906	-50 Reduced 1.18%	4,202 $479,000
Q2 2024 Aug 14, 2024	SELL	$100.73 - $112.44 $2,014 - $2,248	-20 Reduced 0.47%	4,252 $441,000
Q1 2024 May 13, 2024	SELL	$109.52 - $120.96 $14,128 - $15,603	-129 Reduced 2.93%	4,272 $485,000
Q4 2023 Feb 14, 2024	SELL	$90.19 - $110.4 $3.68 Million - $4.5 Million	-40,806 Reduced 90.26%	4,401 $484,000
Q3 2023 Nov 13, 2023	SELL	$95.53 - $114.62 $24,455 - $29,342	-256 Reduced 0.56%	45,207 $4.38 Million
Q2 2023 Aug 14, 2023	SELL	$100.78 - $112.29 $283,091 - $315,422	-2,809 Reduced 5.82%	45,463 $4.96 Million
Q1 2023 May 11, 2023	SELL	$96.86 - $114.01 $57,050 - $67,151	-589 Reduced 1.21%	48,272 $4.89 Million
Q4 2022 Feb 14, 2023	SELL	$95.06 - $111.52 $532,240 - $624,400	-5,599 Reduced 10.28%	48,861 $5.37 Million
Q3 2022 Nov 14, 2022	BUY	$96.76 - $112.03 $117,950 - $136,564	1,219 Added 2.29%	54,460 $5.27 Million
Q2 2022 Aug 12, 2022	SELL	$102.07 - $123.37 $85,738 - $103,630	-840 Reduced 1.55%	53,241 $5.79 Million
Q1 2022 May 09, 2022	BUY	$114.02 - $139.04 $239,213 - $291,705	2,098 Added 4.04%	54,081 $6.4 Million
Q4 2021 Feb 14, 2022	BUY	$115.53 - $141.46 $53,028 - $64,930	459 Added 0.89%	51,983 $7.32 Million
Q3 2021 Nov 12, 2021	SELL	$116.66 - $129.06 $156,207 - $172,811	-1,339 Reduced 2.53%	51,524 $6.09 Million
Q2 2021 Aug 05, 2021	BUY	$105.79 - $124.53 $4.87 Million - $5.74 Million	46,055 Added 676.48%	52,863 $6.13 Million
Q1 2021 May 10, 2021	BUY	$108.84 - $128.23 $1,959 - $2,308	18 Added 0.27%	6,808 $816,000
Q4 2020 Jan 29, 2021	SELL	$105.0 - $114.42 $3,675 - $4,004	-35 Reduced 0.51%	6,790 $743,000
Q3 2020 Oct 26, 2020	SELL	$91.64 - $111.29 $32,074 - $38,951	-350 Reduced 4.88%	6,825 $743,000
Q2 2020 Aug 10, 2020	BUY	$76.57 - $98.0 $47,856 - $61,250	625 Added 9.54%	7,175 $656,000
Q4 2019 Feb 14, 2020	SELL	$78.51 - $87.4 $7,851 - $8,740	-100 Reduced 1.5%	6,550 $569,000
Q3 2019 Nov 15, 2019	SELL	$81.84 - $88.74 $4,910 - $5,324	-60 Reduced 0.89%	6,650 $556,000
Q2 2019 Aug 21, 2019	SELL	$72.88 - $85.0 $13,847 - $16,150	-190 Reduced 2.75%	6,710 $564,000
Q1 2019 May 15, 2019	SELL	$66.22 - $80.06 $29,799 - $36,027	-450 Reduced 6.12%	6,900 $552,000
Q3 2018 Nov 14, 2018	SELL	$60.81 - $73.36 $25,844 - $31,178	-425 Reduced 5.47%	7,350 $539,000
Q2 2018 Aug 14, 2018	SELL	$57.57 - $63.54 $14,392 - $15,885	-250 Reduced 3.12%	7,775 $474,000
Q1 2018 May 10, 2018	SELL	$56.27 - $63.62 $164,252 - $185,706	-2,919 Reduced 26.67%	8,025 $481,000
Q4 2017 Feb 21, 2018	BUY	$53.68 - $57.47 $147,297 - $157,697	2,744 Added 33.46%	10,944 $625,000
Q3 2017 Nov 14, 2017	SELL	$48.06 - $53.64 $14,418 - $16,092	-300 Reduced 3.53%	8,200 $438,000
Q2 2017 Aug 14, 2017	BUY	N/A	8,500	8,500 $413,000

Others Institutions Holding ABT

# of Institutions

3,580

Shares Held

1.39B

Call Options Held

9.73M

Put Options Held

9.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $229B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Colonial Trust Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Colonial Trust Advisors with notifications on news.

Account

Colonial Trust Advisors Abbott Laboratories Transaction History